We're adding to our position in a stock that just got some big support from Wall Street.
Shortly after the bell rings, we will buy 300 shares of Bristol Myers Squibb at approximately $56.50. Following the deal,…
abbvie inc
We want to increase our ownership of a portfolio stock that just increased its dividend.
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Pharmaceutical companies negotiate new prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris…
The 'Trump trade' has split healthcare stocks into two camps. How to play the next moves
This year’s presidential election is already prompting a flurry of health care stocks. Historically, shifts in political control have created…
Humira sales fall, but AbbVie has successors
Humira, the injectable treatment for rheumatoid arthritis, appears at a pharmacy in Cambridge, Massachusetts. JB Reed | Bloomberg | fake…
Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…
AbbVie taps Robert Michael as CEO, replacing Richard González
Test tubes are seen in front of an AbbVie logo in this illustration taken on May 21, 2021. Ruvic Dice…
Varda anti-drug spacecraft gets FAA approval to return
Varda's first manufacturing satellite and reentry vehicle attached to a Rocket Lab Photon bus. rocket laboratory Space startup Varda has…
Here are Jim Cramer's quick takeaways on 6 stocks in Friday's news
Clorox: The consumer products giant saw a huge increase in profits. It is also recovering from last year's cyberattack. “Things…